Suppr超能文献

伴有包膜外扩散的转移性淋巴结体积较小对口腔鳞状细胞癌患者的治疗结果有很大影响。

Small size of metastatic lymph nodes with extracapsular spread greatly impacts treatment outcomes in oral squamous cell carcinoma patients.

作者信息

Michikawa C, Izumo T, Sumino J, Morita T, Ohyama Y, Michi Y, Uzawa N

机构信息

Maxillofacial Surgery, Maxillofacial Reconstruction and Function, Division of Maxillofacial and Neck Reconstruction, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Division of Oral Diagnosis, Dental and Maxillofacial Radiology and Oral Pathology Diagnostic Service, The Nippon Dental University Hospital, Tokyo, Japan.

出版信息

Int J Oral Maxillofac Surg. 2018 Jul;47(7):830-835. doi: 10.1016/j.ijom.2017.12.007. Epub 2018 Jan 17.

Abstract

Extracapsular spread (ECS) of metastatic lymph nodes from oral carcinoma is the most significant prognostic predictor of a poor treatment outcome. However, only a few reports on prognostic factors in ECS-positive cases have been investigated. To address this problem, a detailed examination of ECS pathology was conducted to determine the prognostic factors of oral squamous cell carcinoma (OSCC) with ECS of metastatic lymph nodes. This study involved 63 OSCC patients with at least one pathologically metastatic node with ECS. Among the 229 metastatic lymph nodes, 149 exhibited ECS. Univariate analysis revealed that a poor outcome and recurrence were significantly associated with the number of ECS-positive nodes, density of ECS, and the minor axis of the smallest ECS-positive node. However, multivariate analysis identified only small size of ECS-positive nodes as a significant and independent factor predicting recurrence and a poor outcome. Thus, small size of ECS-positive nodes is the most important prognostic indicator for OSCC with ECS in metastatic lymph nodes. The classification of ECS status using the minor axis of ECS-positive nodes may be useful for further prediction of a poorer prognosis in OSCC cases. Standardization of ECS diagnosis and multicenter prospective studies will be required to confirm and refine these findings.

摘要

口腔癌转移性淋巴结的包膜外扩散(ECS)是治疗效果不佳的最重要预后预测指标。然而,关于ECS阳性病例预后因素的报道较少。为了解决这个问题,对ECS病理进行了详细检查,以确定伴有转移性淋巴结ECS的口腔鳞状细胞癌(OSCC)的预后因素。本研究纳入了63例至少有一个病理证实有ECS的转移性淋巴结的OSCC患者。在229个转移性淋巴结中,149个表现出ECS。单因素分析显示,预后不良和复发与ECS阳性淋巴结数量、ECS密度以及最小ECS阳性淋巴结的短轴显著相关。然而,多因素分析仅确定ECS阳性淋巴结的小尺寸是预测复发和预后不良的一个显著且独立的因素。因此,ECS阳性淋巴结的小尺寸是伴有转移性淋巴结ECS的OSCC最重要的预后指标。使用ECS阳性淋巴结短轴对ECS状态进行分类可能有助于进一步预测OSCC病例的较差预后。需要对ECS诊断进行标准化并开展多中心前瞻性研究以证实和完善这些发现。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验